Showing results (471-480 of 1,014) with videos related to
Sort By:
Pageof 102
Cancer Research Communications|August 12, 2026
Targeting PRMT5 inhibitor-induced adaptation in pancreatic cancer with the RBM39 degrader indisulamValentina Spielmann, Jonas Buchloh, Selen Selcen, et al.Cancer Research Communications|August 19, 2026
Neighborhood factors and treatment outcomes in pediatric acute lymphoblastic leukemia: A REDIAL Consortium reportRutu Rathod, Amy E Hughes, Pagna Sok, et al.Cancer Research Communications|September 15, 2026
SHIVA02 trial: Using patients as their own controls to assess efficacy of therapies based on molecular profiling in patients with refractory cancerPauline du Rusquec, Célia Dupain, Romain Geiss, et al.Cancer Research Communications|September 29, 2026
Auranofin potentiates cisplatin response in the setting of context-dependent NOTCH-associated signaling states in endometrial cancerRobert J Lake, Cynthia Tshibangu, Niko J Candia, et al.Cancer Research Communications|September 22, 2026
Integrated genetic screening identifies FEN1 as a selective vulnerability and temozolomide resistance mediator in glioblastoma stem cellsBenjamin A Brakel, Dillon McKenna, Anish Puri, et al.Cancer Research Communications|October 12, 2026
Nicotinic acid restriction potentiates NAMPT inhibition in acute myeloid leukemia xenograft modelsKyoji Tsurumi, Miyuki Nomura, Mai Ohuchi, et al.Cancer Research Communications|September 18, 2026
Compartment-specific CD8 infiltration and disease-specific survival in resected ampullary adenocarcinomaSteve E Kalloger, Christine Chow, Dongxia Gao, et al.Cancer Research Communications|October 3, 2026
A real-world study of patients with FGFR-altered advanced solid tumors after exhaustion of standard-of-care treatmentLevon Demirdjian, Hussein Sweiti, Raymond Harvey, et al.Cancer Research Communications|October 1, 2026
Setanaxib Added to Pembrolizumab for Fibroblast-Rich, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: a Phase 2 Randomized StudyJérôme Fayette, Gareth J Thomas, Amaury Daste, et al.Cancer Research Communications|October 7, 2026
ERX 208 induces endoplasmic reticulum stress and suppresses DNA damage repair to enhance chemotherapy sensitivityDurga Meenakshi Panneerdoss, Khaled Mohamed Nassar, Baskaran Subramani, et al.Pageof 102